Goldman Sachs analyst Rajan Sharma initiates coverage on GSK (NYSE:GSK) with a Neutral rating and announces Price Target of $47.
Goldman Sachs Initiates Coverage On GSK With Neutral Rating, Announces Price Target of $47
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.